Qiara Pregnancy & Breastfeeding

A probiotic isolated from breast milk

Qiara Pregnancy & Breastfeeding contains the patented probiotic strain Lactobacillus Fermentum CECT5716, originally isolated from breast milk, which may help:

  • maintain a healthy microflora, important for you and your baby before, during and after pregnancy
  • restore balance of good bacteria in breastmilk that may have been disrupted by antibiotics
  • relieve or reduce breast pain and discomfort associated with mastitisreduce the recurrence of mastitis 

Take Qiara Pregnancy & Breastfeeding from preconception, your last trimester, or throughout your entire pregnancy and breastfeeding.

Costing less than a cup of coffee, simply stir one sachet per day into a glass of water and  keep breastfeeding with Qiara.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Aliquam luctus nibh sapien. Curabitur luctus enim rhoncus augue tincidunt faucibus. Duis molestie magna a enim sagittis ultrices. Ut sagittis ac quam eget tristique.

Learn more

Pregnancy & Breastfeeding

A mother’s healthy microbiome and breast milk (a main source of nutrition for her infant), can have a significant impact on the overall health of both baby and mother as well as the establishment of a baby’s own microbiome.

Qiara may be particularly useful as a supplement where a mother's natural microbiome may be disrupted by external factors such as antibiotics, as a treatment for infection or after a c-section, or in GBS positive mothers.

Breast Pain & Mastitis

Research conducted using the single probiotic strain in Qiara, shows that it may:

Qiara achieves this by aggressively outcompeting pathogenic (bad) bacteria in breast milk to help maintain a healthy balance in the breast milk microflora ecosystem. Simply take Qiara at the first signs of breast pain or mastitis.

Having a C-Section?
A study of 627,600 Australian births reported that women who gave birth by C-Section were 70% more likely to be diagnosed with a complication affecting breastfeeding and their babies are at higher risk of infection.

C-section mums are routinely administered antibiotics to prevent infection which lower the levels of good bacteria in breast milk which may lead to an imbalance between good and bad bacteria (dysbiosis). Lower levels of good bacteria may increase the potential for bad bacteria to flourish which may lead to breast pain and mastitis. Taking Qiara daily before and after your C-section may assist in maintaining the balance of good bacteria in breast milk.

Group B Streptococcus (GBS) positive?
Group B Streptococcus (GBS) is a type of bacteria that can cause illness in people of all ages. Anywhere from 10-30% of pregnant women carry GBS in their bodies. Many hospitals and obstetricians routinely swab for GBS during pregnancy. If your health professional recommends antibiotics in labour following a GBS positive swab, commence Qiara immediately and continue after birth and while breastfeeding to increase levels of good bacteria that may be disrupted.

Breastfeeding
A mother’s microbiome and breast milk can have a significant impact on the overall health of both baby and mother as well as the establishment of her baby’s own microbiome. Breastfeeding continues the important transfer of beneficial bacteria that begins during pregnancy. Qiara Pregnancy & Breastfeeding is a single strain probiotic isolated from human breast milk. Take one sachet daily while breastfeeding.

Pregnancy
Our microbiome begins its colonisation in the womb, is further impacted by the method of delivery and continues its development during breast feeding. An infant’s microbiome is fully established by the time it is 3 years old. So a healthy and robust microbiome before and during pregnancy, birth and lactation has life long benefits for the infant. Qiara may help maintain a healthy digestive microflora system. Take one sachet daily during pregnancy.

Preconception
Research has shown that a baby inherits many health traits from its parents at conception, so establishing good gut health can have lifelong benefits for your baby. For more tips on the role breast milk isolated probiotics can play when planning for a baby, seehttp://www.conceivebaby.com.au/fertility-microbiome-probiotics-need-know/

Dosage
Add contents of one sachet to a glass of water or milk, stir and consume immediately. Take one sachet per day. Up to two sachets can be taken daily. Two sachets per day is recommended if you are taking antibiotics. Take Qiara 2-3 hours away from your antibiotic dosage. Qiara can be taken pre-conception and throughout the entire pregancy, breastfeeding and post-weaning.

IF SYMPTOMS PERSIST SEEK MEDICAL ADVICE

The Qiara Guarantee

Isolated from breastmilk

Lactobacillus Fermentum CECT 5716 is a probiotic isolated from breast milk which:

So it's safe for both mother and baby and may play a critical role in establishing a healthy microbiome of the infant for life.

Single strain: The difference between promises and results is research. It is important to select the right probiotic strain researched for and suited to your needs.

Many probiotic companies provide broad spectrum probiotics containing multiple strains in a single dose. However, clinical trials for probiotics are usually conducted with a single strain rather than with mulitple strains, and it is unclear how multiple strains in a single dosage may interact with or inhibit each other.  That is why Qiara Pregnancy & Breastfeeding contains 3 billion microorganisms of Lactobacillus Fermentum CECT 5716, the same dosage of a single strain used in clinical trials.

References

Arroyo R, Martín V, Maldonado A, Jiménez E, Fernández L, Rodríguez JM (2010) Treatment of infectious mastitis during lactation: antibiotics versus oral administration of Lactobacilli isolated from breast milk. Clin Infect Dis. 2010 Jun 15;50(12):1551-8. doi: 10.1086/652763.

Maldonado-Lobón JA, et al. (2015) Lactobacillus fermentum CECT 5716 Reduces Staphylococcus Load in the Breastmilk of Lactating Mothers Suffering Breast Pain: A Randomized Controlled Trial. Breastfeeding Medicine 10(9), pp. 425-432. doi:10.1089/bfm.2015.0070

Soto A, Martín V, Jiménez E, Mader I, Rodríguez JM, Fernández L. Lactobacilli and Bifidobacteria in human breast milk: influence of antibiotherapy and other host and clinical factors. J Pediatr Gastroenterol Nutr. 2014;59:78–88.

Martín, R., Heiling, H.G.H.J., Zoetendal, E.G., Smidt, H., Rodríguez, J.M. (2007) Diversity of the Lactobacillus group in breast milk and vagina of healthy women and potential role in the colonization of the infant gut. J. Appl. Microbiol. 103, 2638-2644.